Financhill
Back

Catalyst Pharmaceuticals Vs. Vertex Pharmaceuticals Industry Stock Comparison

Sell
35

CPRX
Catalyst Pharmaceuticals

Last Price:
20.00
Seasonality Move:
-6.53%
Sell
41

VRTX
Vertex Pharmaceuticals

Last Price:
455.34
Seasonality Move:
5.22%
Sell
35
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $20.00. The Score for CPRX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Vertex Pharmaceuticals (VRTX) is a Sell

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $455.31. The Score for VRTX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $20.00
    The current trend is relatively stagnant and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $455.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight selling pressure.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.12 Buy
Relative Strength Index (14 RSI): 51 Buy
Chaikin Money Flow: -292033 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.65 - 20.53) Sell
Bollinger Bands (100): (15.7 - 19.74) Buy

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.49 Sell
Relative Strength Index (14 RSI): 38.19 Sell
Chaikin Money Flow: -19753 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (460.67 - 481.05) Sell
Bollinger Bands (100): (458.48 - 489.66) Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.94 Buy
20-day SMA: 20.15 Sell
50-day SMA: 19.43 Buy
200-day SMA: 16.48 Buy
8-day EMA: 20.03 Sell
20-day EMA: 20.04 Sell
50-day EMA: 19.34 Buy
200-day EMA: 16.92 Buy

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 461.71 Sell
20-day SMA: 469.24 Sell
50-day SMA: 476.71 Sell
200-day SMA: 444.79 Buy
8-day EMA: 461.33 Sell
20-day EMA: 467.3 Sell
50-day EMA: 472 Sell
200-day EMA: 442.99 Buy

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.90 per share, and an increase next year of $18.27 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):